论文部分内容阅读
Fortunately,the landscape of the systemic treatment for grade 1 and 2 pancreatic neuroendocrine tumors has changed in the last decade with at least four different alternatives approved in the field.Chemotherapy,somatostatin analogues,sunitinib and everoli